Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Hedgehog Drug Helps Late-Stage Cancers

Advanced Skin, Brain Cancers Improve With Experimental Hedgehog Drug
WebMD Health News
Reviewed by Louise Chang, MD

Sept. 2, 2009 -- People with advanced skin and brain cancers -- untreatable by current methods -- improve after treatment with a new oral drug called a hedgehog inhibitor.

Hedgehog is one of the hottest new anticancer targets. During embryonic development and childhood, the signaling molecule nicknamed hedgehog spurs growth processes. But the body turns it off during adulthood. When hedgehog isn't turned off, it promotes the growth of cancer cells.

An experimental drug code-named GDC-0449 by developer Genentech blocks hedgehog. Can it fight cancer?

Some cancer types are particularly dependent on hedgehog. One is basal cell carcinoma, the most common skin cancer in the U.S. Although surgery can cure this cancer in early disease, metastatic disease has no standard treatment and usually is rapidly fatal.

Can GDC-0449 help? In a Genentech-funded study, Daniel D. Von Hoff, MD, of Scottsdale Healthcare and colleagues gave the drug to 33 patients with inoperable metastatic or locally advanced basal cell carcinoma.

"The overall response rate was 55%, with a remarkable response rate of 50% in 18 patients with metastatic disease," University of Michigan researchers Andrzej A. Dlugosz, MD, and Moshe Talpaz, MD, note in an editorial accompanying the study in the Sept. 2 online edition of The New England Journal of Medicine.

Only four of the patients had continued progression of their cancers over the course of the 10-month study. There were relatively few adverse events linked to the treatment.

In another Genentech-funded study published in the same issue of The New England Journal of Medicine, Johns Hopkins researcher Charles M. Rudin, MD, PhD, and colleagues report the treatment of a brain cancer -- medulloblastoma -- with GDC-0449.

Medulloblastoma -- cancer of the part of the brain called the cerebellum -- usually strikes at about age 5 years. But it can strike in early adulthood, too. The patient seen by Rudin and colleagues was 26, and had been fighting the disease for four years. Most people die of this cancer in less than six months.

The man survived extensive surgeries, radiation therapies, and chemotherapies. But at the time he was treated with GDC-0449, scans showed that the cancer had spread painfully throughout his body.

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas